Avances terapéuticos en la deshabituación tabáquica

Jiménez Ruiz, C.A.

doi:10.1016/S0300-2896(15)30035-1

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and basic research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 35. Issue 9.

Pages 415-416 (October 1999)

More article options

Pages 415-416 (October 1999)

DOI: 10.1016/S0300-2896(15)30035-1

Full text access

Avances terapéuticos en la deshabituación tabáquica

Visits

3533

Download PDF

C.A. Jiménez Ruiz

Corresponding author

Cjimenez@hup.es

Correspondencia: Servicio de Neumología. Hospital Universitario de la Princesa. Diego de León, 62. 28006 Madrid.

Unidad de Tabaquismo. Servicio de Neumología. Hospital Universitario de la Princesa. Madrid

This item has received

3533 Visits

Article information

Bibliography

Download PDF

Statistics

Full text is only aviable in PDF

Bibliografía

[1.]

Department of Health, Human Services (PHS).

The health consequences of smoking: nicotine addiction.

A report of the Surgeon General DHHS (CDC), Govermment printing office, (1988),

[2.]

American Psychiatric Association.

Practice guidelines for the treatment of patients with nicotine dependence.

Am J Psychiatry, 153 (1996), pp. 1-31

Medline

[3.]

J.E. Henningfield, L.M. Schuh, M.E. Jarvik.

Pathophysiology of tobacco dependence.

Psychopharmacology. The fourth generation of progress, pp. 1.715-1.729

[4.]

N.L. Benowitz.

Nicotine pharmacology and addiction.

Nicotine safety and toxicity, pp. 3-16

[5.]

J.R. Hughes, D. Hatsukami.

Signs and symptoms of tobacco withdrawal.

Arch Gen Psychiatry, 43 (1986), pp. 289-294

Medline

[6.]

K.E. Warner.

Smoking cessation: a global prespective.

J Respir Dis, 19 (1998), pp. 526-532

[7.]

C. Silagy, D. Mant, G. Fowler, T. Lancaster.

Nicotine replacement therapy for smoking cessation, Cochrane, collaboration.

Cochrane library, Update software, (1998),

[8.]

J.L. Tang, M. Law, N. Wald.

How effective is nicotine replacement therapy in helping people to stop smoking.

BMJ, 308 (1994), pp. 21-26

Medline

[9.]

L.H. Ferry, R.J. Burchette.

Efficacy of bupropion for smoking cessation in non-depressed smokers.

J Addict Dis, 13 (1994), pp. 249

[10.]

R.D. Hurt, D. Sachs, E.D. Glover, K.P. Offord, J.A. Johnston, L.C. Dale, et al.

A comparison of sustained-release bupropion and placebo for smoking cessation.

N Engl J Med, 337 (1997), pp. 1.195-1.202

http://dx.doi.org/10.1056/NEJM199710023371404 | Medline

[11.]

D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, A.R. Hughes, et al.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

N Engl J Med, 340 (1999), pp. 685-691

http://dx.doi.org/10.1056/NEJM199903043400903 | Medline

[12.]

C.A. Jiménez Ruiz, K.O. Fagerström.

Reducción del consumo del tabaco.

¿Una estrategia para dejar de fumar?. Arch Bronconeumol, 35 (1999), pp. 229-232

[13.]

C.A. Jiménez Ruiz, M. Kunze, K.O. Fagerström.

Nicotine replacement: a new approach to reducing tobacco-related harm.

Eur Respir J, 11 (1998), pp. 473-479

Medline

[14.]

C. Fiore, D.W. Wetter, W.C. Bailey, G. Bennett, S.J. Cohen, Dorfaman, et al.

The Agency for health care policy and research smoking cessation clinical practice guideline.

JAMA, 275 (1996), pp. 1.270-1.280

Medline

[15.]

P. Tønnessen.

Nicotine replacement and other drugs in smoking cessation.

The tobáceo epidemic, pp. 178-189

[16.]

D.E. Jorenby, S.S. Stevens, M.C. Fiore, R.D. Hurt, K.P. Offord, I.T. Croghan, et al.

Varying nicotine patch dose and type of smoking cessation counselling.

JAMA, 274 (1995), pp. 1.347-1.352

Medline

[17.]

P. Tønnessen, P. Paoletti, G. Gustavsson, M.A.H. Russell, R. Saracci, A. Gulsvik, et al.

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial.

Eur Respir J, 13 (1999), pp. 238-246

Medline

[18.]

J. Stapleton.

Progress on nicotine replacement therapy for smokers.

BMJ, 318 (1999), pp. 289

Medline

[19.]

M. Kornitzer, M. Boutsen, M. Dramaix, J. Thijs, G. Gustavsson.

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Prev Med, 24 (1995), pp. 41-47

http://dx.doi.org/10.1006/pmed.1995.1006 | Medline

[20.]

P. Puska, H.J. Korhonen, E. Vartiainen, E.L. Urganhevmo, G. Gustavsson, A. Westin.

Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia.

Tobacco control, 4 (1995), pp. 231-235

[21.]

Bohadana AB, Nilsson F, Martinet Y. Nicotine inhaler and nicotine patch: a combination therapy for smoking cessation. Comunicación presentada en The First International Conference of the Society for Research on Nicotine and Tobacco. Copenhague, 22-23 de agosto de 1998.

[22.]

T. Bondal, L.J. Gudmundsson, I. Olafsdottir, G. Gustavsson, A. Westin.

Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.

BMJ, 318 (1999), pp. 285-289

Medline

[23.]

J.E. Henningfield, R.V. Fant, L. Gopalan.

Non-nicotine mediactions for smoking cessation.

J Respir Dis, 19 (1998), pp. 533-542

[24.]

V. O’Brien.

Nicorette usage: an attitude study.

Europe-96. The decision shop, (1996),

[25.]

Jiménez Ruiz CA. The efficacy and safety of nicotine gum in smoking reduction: a double-blind randomised placebo-controlled clinical study. Ponencia presentada en la 10th International Conference on Harm Reduction. Ginebra, 20-25 de marzo de 1999.